Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
STAG3L1 is defined in databases as a pseudogene that is homologous to STAG3, a key component of the cohesin complex integral for sister chromatid cohesion in mitosis and meiosis[1][6]. While the cohesin complex—and specifically proteins like STAG3, STAG1, and STAG2—are essential for chromosome segregation, genome stability, and are implicated in various diseases including cancer and developmental disorders[3][4][5], STAG3L1 lacks evidence for encoding a functional protein and is not considered a validated molecular target or receptor[1][6][8]. STAG3, and not STAG3L1, plays established roles in chromosome segregation, meiosis, and has disease relevance[4][8]. The STAG proteins (STAG1, STAG2, STAG3) are core cohesin components, participating in chromatin organization and regulation, but STAG3L1 is annotated as a pseudogene and there is no evidence of it being translated or acting as a therapeutic target[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on STAG3 cohesin complex component like 1 (STAG3L1).